A Phase II Study of Parotid-gland Sparing IMRT in Patients With Midline Tumour of the Head and Neck
Conditions
- Oropharyngeal Squamous Cell Cancer
- Hypopharyngeal Squamous Cell Cancer
Interventions
- RADIATION: Intensity modulated radiotherapy
Sponsor
Royal Marsden NHS Foundation Trust